Skip to main content
. 2019 Dec 16;9:19162. doi: 10.1038/s41598-019-55631-8

Figure 4.

Figure 4

Heme treatment affects ERBB4 and NRG-1 expression in iPSCs. iPSCs were treated with heme for 18 hours. The number of cells positive for ERBB4 was assessed using flow cytometry analysis. The ERBB4 and endogenous NRG-1 (eNRG-1) protein expression levels were determined using Western blotting. (A) Representative flow cytometry results illustrating the percent of iPSCs that express ERBB4. (B) The number of cells positive for ERBB4 increased as the heme-induced injury level increased. (C) Cell lysates from iPSCs treated with various heme doses were immunoblotted for ERBB4 and NRG-1. Western blot densitometry analysis was performed using the ImageJ program (full blots are shown in the Supplementary Information file, Supplementary Fig. S1). The results show that NRG-1 expression levels increased as the heme concentration increased, while ERBB4 expression decreased in a similar manner (a: p < 0.05 compared to basal conditions; b: p < 0.05 compared to 10 µM treatment).